Merck: FDA to Speed Review on Gardasil’s Use in Adult Women

efluxmedia: "Drug maker Merck & Co. announced Wednesday that the U.S. Food and Drug Administration would consider whether to expand use of Gardasil, intended to prevent cervical cancer to women aged 27 to 45.

Gardasil, is currently approved in the United States for use in girls and women aged 9 through 26 to block four types of human papilloma virus, which can cause cervical cancer and genital warts."